Barclays PLC Insmed Inc Call Options Transaction History

Barclays PLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $297,000 - $941,084	13,500 Added 24.64%	68,300 $4.58 Million
Q1 2024 May 15, 2024	BUY	$25.72 - $29.94 $1.41 Million - $1.64 Million	54,800 New	54,800 $1.49 Million
Q4 2019 Feb 10, 2020	BUY	$16.12 - $24.98 $2.29 Million - $3.55 Million	142,000 Added 47333.33%	142,300 $3.4 Million
Q1 2019 May 15, 2019	BUY	$13.91 - $31.15 $2,782 - $6,230	200 Added 200.0%	300 $9,000
Q1 2018 May 15, 2018	SELL	$21.69 - $32.99 $1.27 Million - $1.93 Million	-58,600 Reduced 99.83%	100 $2,000
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $681,507 - $1.83 Million	58,700	58,700 $1.83 Million

481

182M

2.27M

3.32M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.8B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.